Psychometric Testing of the Chinese Version of the Clinically Useful Depression Outcome Scale in Patients with Diabetes

Thursday, 2 August 2012: 9:10 AM

Pei-Shan Tsai, PhD
Graduate Institute of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan

Learning Objective 1: describe the procedures used to examine the psychometric properties of an instrument.

Learning Objective 2: describe the validity and reliability of the Chinese version of the Clinically Useful Depression Outcome Scale.

Purpose:

The purpose of this study was to test the psychometric properties of the Clinically Useful Depression Outcome Scale (CUDOS) in Taiwanese diabetic patients.   

Methods:

The CUDOS contains 18 items covering the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition symptoms of major depressive disorder and dysthymic disorder. Each item is scored a 5-point Likert scale (0 – 4) with a score ranging from 0 to 72. Following the standard translation-back translation procedure, the CUDOS was translated into Chinese. Internal consistency was examined by the Cronbach’s alpha. All participants filled out the Beck Depression Inventory-II (BDI-II), Beck Anxiety Inventory (BAI), and the World Health Organization Quality of Life-BREF (WHOQOL-BREF), Taiwan Version, along with the CUDOS. To assess test-retest reliability, the participants were asked to fill out the CUDOS on a second occasion at a 7-day interval.

Results:

Included in the study were 153 diabetics, including 132 patients without and 21 patients with depression. The CUDOS scores were significantly different between patients with depression and those without (p < 0.001). The Cronbach’s alpha was 0.93 for the CUDOS. The test-retest correlation coefficient was 0.83. The CUDOS significantly and positively correlated to BDI-II (r = 0.88, p < 0.001) and BAI (r = 0.78, p < 0.001) and inversely correlated to the WHOQOL-BREF (r = -0.32, p < 0.001). The CUDOS score significantly and independently predicted quality of life after adjusting for possible confounders.

Conclusion:

The Chinese version of the CUDOS demonstrated satisfactory reliability and validity for use in the Taiwanese diabetic patients.